$ Value
$2K
Shares
2,382
Price
$1
Filed
Aug 19
Insider
Name
Lettmann Jason
Title
CHIEF EXECUTIVE OFFICER
CIK
0001688269
Roles
Transaction Details
Transaction Date
2025-08-15
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
212,888
Footnotes
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. | Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2025.
Filing Info
Lettmann Jason's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-14 | ALXO | A | $0 |
| 2025-09-17 | ALXO | ▲ | $77K ★ |
| 2025-09-16 | ALXO | ▲ | $22K |
| 2025-08-15 | ALXO | ▼ | $2K |
Other Insiders at ALXO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Klencke Barbara
Chief Medical Officer
|
— | — | 2026-04-16 |
|
Knight Jeff E.
Chief Dev & Operating Officer
|
— | — | 2026-04-16 |